Lv2
170 积分 2023-08-04 加入
Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002)
1个月前
已完结
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma
3个月前
已完结
Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085
5个月前
已完结
Cholesterol biosynthesis induced by radiotherapy inhibits cGAS–STING activation and contributes to colorectal cancer treatment resistance
5个月前
已完结
Venetoclax Synergizes With Regorafenib for Colorectal Cancer by Targeting BCL‐2
5个月前
已完结
Update on Management of Squamous Cell Esophageal Cancer
6个月前
已完结
Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
6个月前
已完结
Treatments for esophageal cancer: a review
6个月前
已完结
Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma
6个月前
已完结
皖公网安备34019202002308
